Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform. Bojkova et al
Published: 4 January 2023| Version 1 | DOI: 10.17632/yzbfm4v7y7.1
This table presents the results from a screen of kinase inhibitors for activity against a SARS-CoV-2 Delta isolate. Caco-2-F03 cells were infected with an MOI of 0.01 and virus infection was monitored using caspase 3/7 activity as read-out.
University of Kent, Goethe-Universitat Frankfurt am Main
Pharmacology, Virology, Drug Screening